Evidence map›Paper›PMID 38675027›Full record

ArticlePolymers2024

Novel Biocomposite of Starch and Flax Fiber Modified with Tannic Acid with Biocidal Properties.

Magdalena Stepczyńska, Piotr Rytlewski, Krzysztof Moraczewski, Alona Pawłowska, Tomasz Karasiewicz

Abstract read
In one paragraph

Article in Polymers, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Modifying Polylactide with Powdered Cork Filler.Materials (Basel, Switzerland) · 2025
    Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Magdalena StepczyńskaFaculty of Materials Engineering, Kazimierz Wielki University, Jana Karola Chodkiewicza 30, 85-064 Bydgoszcz, Poland.ORCID 0000-0002-9728-5633
Piotr RytlewskiFaculty of Materials Engineering, Kazimierz Wielki University, Jana Karola Chodkiewicza 30, 85-064 Bydgoszcz, Poland.
Krzysztof MoraczewskiFaculty of Materials Engineering, Kazimierz Wielki University, Jana Karola Chodkiewicza 30, 85-064 Bydgoszcz, Poland.ORCID 0000-0003-4188-8408
Alona PawłowskaFaculty of Materials Engineering, Kazimierz Wielki University, Jana Karola Chodkiewicza 30, 85-064 Bydgoszcz, Poland.
Tomasz KarasiewiczFaculty of Materials Engineering, Kazimierz Wielki University, Jana Karola Chodkiewicza 30, 85-064 Bydgoszcz, Poland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The purpose of this paper was to develop novel biocomposites with biocidal properties in microorganisms, with enhanced mechanical strength and hydrophobicity as well as with increased biodegradation rates. The main idea and the novelty of this work was to use cross-linking compounds and, at the same time, biocidal compounds-natural compounds of plant origin with biocidal properties. The authors assumed that the modification of flax fiber by natural plant compound will reduce the hydrophilicity of novel biocompositie. Biopolymer based on thermoplastic starch reinforced with flax fibres modified with tannic acid (TA) was prepared by extrusion and injection molding processes. The effects of TA modification on the mechanical and structural properties of biocomposites were analyzed through DMA, tensile tests, DSC, and TG. The biocidal and wettability properties of the biocomposites were investigated. The article also discusses the outcomes of research conducted on the structural characteristics and rates of the biodegradation of biocomposites.

Indexed as

biocompositiesfibers modificationflax fibersnatural biocidal compoundstannic acidthermoplastic starch

Identifiers

PMID38675027
PMCPMC11054732

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.